Lista de obras -

APOE-dependent phenotypes in subjects with mild cognitive impairment converting to Alzheimer's disease

artículo científico publicado en 2013

Add-on Antidepressants in the Naturalistic Treatment of Schizophrenia Spectrum Disorder - When, Who, and How?

artículo científico publicado en 2017

Akathisia and suicidal ideation in first-episode schizophrenia

artículo científico publicado en 2012

An early improvement threshold to predict response and remission in first-episode schizophrenia

artículo científico publicado en 2010

Apolipoprotein E-dependent load of white matter hyperintensities in Alzheimer's disease: a voxel-based lesion mapping study

artículo científico publicado en 2015

Association of SORL1 gene variants with Alzheimer's disease

artículo científico publicado en 2009

Atrophy outcomes in multicentre clinical trials on Alzheimer's disease: effect of different processing and analysis approaches on sample sizes

artículo científico publicado en 2011

Attitude towards adherence in patients with schizophrenia at discharge

artículo científico publicado en 2009

Atypical symptoms in hospitalised patients with major depressive episode: frequency, clinical characteristics, and internal validity

artículo científico publicado en 2007

Author Correction: Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing

scientific article published on 01 September 2019

Clinical predictors of response and remission in inpatients with depressive syndromes

artículo científico publicado en 2011

Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease

artículo científico publicado en 2011

Defining and predicting functional outcome in schizophrenia and schizophrenia spectrum disorders

artículo científico publicado en 2009

Depression during an acute episode of schizophrenia or schizophreniform disorder and its impact on treatment response

artículo científico publicado en 2008

Depressive symptoms and their association with acute treatment outcome in first-episode schizophrenia patients: comparing treatment with risperidone and haloperidol

artículo científico publicado en 2011

Do efficacy and effectiveness samples differ in antidepressant treatment outcome? An analysis of eligibility criteria in randomized controlled trials

artículo científico publicado en 2010

Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression

artículo científico publicado en 2008

Early and differential diagnosis of dementia and mild cognitive impairment: design and cohort baseline characteristics of the German Dementia Competence Network

artículo científico publicado en 2009

Erratum: Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease

scholarly article published in Nature Genetics

Erratum: Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease

article

Evaluating depressive symptoms in schizophrenia: a psychometric comparison of the Calgary Depression Scale for Schizophrenia and the Hamilton Depression Rating Scale

artículo científico publicado en 2012

Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer's disease

artículo científico publicado en 2010

Genetic interaction of PICALM and APOE is associated with brain atrophy and cognitive impairment in Alzheimer's disease

artículo científico publicado en 2014

Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing

artículo científico publicado en 2019

Genetics of emergent suicidality during antidepressive treatment--data from a naturalistic study on a large sample of inpatients with a major depressive episode

artículo científico publicado en 2012

Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease

artículo científico publicado en 2009

Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementia

artículo científico publicado en 2017

Influence of SORL1 gene variants: association with CSF amyloid-beta products in probable Alzheimer's disease

artículo científico publicado en 2008

Influencing factors and predictors of early improvement in the acute treatment of schizophrenia and schizophrenia spectrum disorder

artículo científico publicado en 2011

Left anterior temporal lobe sustains naming in Alzheimer's dementia and mild cognitive impairment

artículo científico

Measurement of ERK 1/2 in CSF from patients with neuropsychiatric disorders and evidence for the presence of the activated form

artículo científico publicado en 2009

Multicentre variability of MRI-based medial temporal lobe volumetry in Alzheimer's disease

artículo científico publicado en 2010

No influence of brain-derived neurotrophic factor (BDNF) polymorphisms on treatment response in a naturalistic sample of patients with major depression

artículo científico publicado en 2012

One-year functional outcomes of naturalistically treated patients with schizophrenia

artículo científico publicado en 2012

Outcomes of 1014 naturalistically treated inpatients with major depressive episode

artículo científico publicado en 2010

Predictors of relapse in the year after hospital discharge among patients with schizophrenia

artículo científico publicado en 2012

Predictors of response and remission in the acute treatment of first-episode schizophrenia patients — Is it all about early response?

article by Rebecca Schennach-Wolff et al published May 2011 in European Neuropsychopharmacology

Psychopathological characteristics and treatment response of first episode compared with multiple episode schizophrenic disorders

artículo científico publicado en 2007

Quality of life and subjective well-being in schizophrenia and schizophrenia spectrum disorders: valid predictors of symptomatic response and remission?

artículo científico publicado en 2010

Remission and recovery and their predictors in schizophrenia spectrum disorder: results from a 1-year follow-up naturalistic trial

artículo científico publicado en 2012

Response trajectories in "real-world" naturalistically treated schizophrenia patients

artículo científico publicado en 2012

The controversial link between antidepressants and suicidality risks in adults: data from a naturalistic study on a large sample of in-patients with a major depressive episode

artículo científico publicado en 2008

The role of variation at AβPP, PSEN1, PSEN2, and MAPT in late onset Alzheimer's disease

artículo científico publicado en 2012

Three-Year long-term outcome of 458 naturalistically treated inpatients with major depressive episode: severe relapse rates and risk factors

artículo científico publicado en 2014

Lista de obras de

APOE-dependent phenotypes in subjects with mild cognitive impairment converting to Alzheimer's disease

Add-on Antidepressants in the Naturalistic Treatment of Schizophrenia Spectrum Disorder - When, Who, and How?

Akathisia and suicidal ideation in first-episode schizophrenia

An early improvement threshold to predict response and remission in first-episode schizophrenia

Apolipoprotein E-dependent load of white matter hyperintensities in Alzheimer's disease: a voxel-based lesion mapping study

Association of SORL1 gene variants with Alzheimer's disease

Atrophy outcomes in multicentre clinical trials on Alzheimer's disease: effect of different processing and analysis approaches on sample sizes

Attitude towards adherence in patients with schizophrenia at discharge

Atypical symptoms in hospitalised patients with major depressive episode: frequency, clinical characteristics, and internal validity

Author Correction: Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing

Clinical predictors of response and remission in inpatients with depressive syndromes

Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease

Defining and predicting functional outcome in schizophrenia and schizophrenia spectrum disorders

Depression during an acute episode of schizophrenia or schizophreniform disorder and its impact on treatment response

Depressive symptoms and their association with acute treatment outcome in first-episode schizophrenia patients: comparing treatment with risperidone and haloperidol

Do efficacy and effectiveness samples differ in antidepressant treatment outcome? An analysis of eligibility criteria in randomized controlled trials

Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression

Early and differential diagnosis of dementia and mild cognitive impairment: design and cohort baseline characteristics of the German Dementia Competence Network

Erratum: Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease

Erratum: Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease

Evaluating depressive symptoms in schizophrenia: a psychometric comparison of the Calgary Depression Scale for Schizophrenia and the Hamilton Depression Rating Scale

Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer's disease

Genetic interaction of PICALM and APOE is associated with brain atrophy and cognitive impairment in Alzheimer's disease

Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing

Genetics of emergent suicidality during antidepressive treatment--data from a naturalistic study on a large sample of inpatients with a major depressive episode

Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease

Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementia

Influence of SORL1 gene variants: association with CSF amyloid-beta products in probable Alzheimer's disease

Influencing factors and predictors of early improvement in the acute treatment of schizophrenia and schizophrenia spectrum disorder

Left anterior temporal lobe sustains naming in Alzheimer's dementia and mild cognitive impairment

Measurement of ERK 1/2 in CSF from patients with neuropsychiatric disorders and evidence for the presence of the activated form

Multicentre variability of MRI-based medial temporal lobe volumetry in Alzheimer's disease

No influence of brain-derived neurotrophic factor (BDNF) polymorphisms on treatment response in a naturalistic sample of patients with major depression

One-year functional outcomes of naturalistically treated patients with schizophrenia

Outcomes of 1014 naturalistically treated inpatients with major depressive episode

Predictors of relapse in the year after hospital discharge among patients with schizophrenia

Predictors of response and remission in the acute treatment of first-episode schizophrenia patients — Is it all about early response?

Psychopathological characteristics and treatment response of first episode compared with multiple episode schizophrenic disorders

Quality of life and subjective well-being in schizophrenia and schizophrenia spectrum disorders: valid predictors of symptomatic response and remission?

Remission and recovery and their predictors in schizophrenia spectrum disorder: results from a 1-year follow-up naturalistic trial

Response trajectories in "real-world" naturalistically treated schizophrenia patients

The controversial link between antidepressants and suicidality risks in adults: data from a naturalistic study on a large sample of in-patients with a major depressive episode

The role of variation at AβPP, PSEN1, PSEN2, and MAPT in late onset Alzheimer's disease

Three-Year long-term outcome of 458 naturalistically treated inpatients with major depressive episode: severe relapse rates and risk factors